ArticleRSC medicinal chemistry2023

Selective isoxazolopyrimidine PAT1 (SLC26A6) inhibitors for therapy of intestinal disorders.

Tifany Chu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.